Co-authored publications

Brad Jones, PhD and Itzayana Miller · 6 publications

CSV Word

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.
Nature immunology · 2026
BJBrad JonesIMItzayana MillerADAli Danesh MCMarina CaskeyMCMichel C Nussenzweig
PMID: 41776101PMCID: PMC13043296DOI2 citations
Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGF-β1 signaling.
JCI insight · 2026
BJBrad JonesIMItzayana MillerADAli Danesh JCJeffrey C Laurence
PMID: 41774493PMCID: PMC13460851DOI
Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones.
Nature · 2026
BJBrad JonesIMItzayana MillerIFIsabella FerreiraAHAlberto HerreraNLNoemi Linden+14 more →
PMID: 41735521PMCID: PMC13190302DOI3 citations
HIV-1 Integration Site Determines the Transcriptional Fate and Persistence of Integrated Proviruses.
bioRxiv : the preprint server for biology · 2026
BJBrad JonesIMItzayana MillerADAli Danesh GQGuinevere Q. Lee
PMID: 41509258PMCID: PMC12776120DOI
EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8⁺ T cells toward less-exhausted phenotypes.
Cell reports · 2025
BJBrad JonesIMItzayana MillerAGAndrea Gramatica PZPaul Zumbo LNLouise Noelie Josephine Leyre+7 more →
PMID: 40333189PMCID: PMC13088201DOI13 citations
A Participant-Derived Xenograft Mouse Model to Decode Autologous Mechanisms of HIV Control and Evaluate Immunotherapies.
Bio-protocol · 2025
BJBrad JonesIMItzayana MillerADAli Danesh
PMID: 40224654PMCID: PMC11986693DOI2 citations